104 related articles for article (PubMed ID: 26397041)
1. Silencing β-linked N-acetylglucosamine transferase induces apoptosis in human gastric cancer cells through PUMA and caspase-3 pathways.
Wen T; Hou K; Li Z; Li L; Yu H; Liu Y; Li Y; Yin Z
Oncol Rep; 2015 Dec; 34(6):3140-6. PubMed ID: 26397041
[TBL] [Abstract][Full Text] [Related]
2. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
3. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
4. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
Zhang N; Chen X
Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
[TBL] [Abstract][Full Text] [Related]
5. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.
Mi W; Gu Y; Han C; Liu H; Fan Q; Zhang X; Cong Q; Yu W
Biochim Biophys Acta; 2011 Apr; 1812(4):514-9. PubMed ID: 21255644
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAcylation is associated with the development and progression of gastric carcinoma.
Jang TJ; Kim UJ
Pathol Res Pract; 2016 Jul; 212(7):622-30. PubMed ID: 27131860
[TBL] [Abstract][Full Text] [Related]
8. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
10. miR-483 is down-regulated in gastric cancer and suppresses cell proliferation, invasion and protein O-GlcNAcylation by targeting OGT.
Yu FY; Zhou CY; Liu YB; Wang B; Mao L; Li Y
Neoplasma; 2018 Mar; 65(3):406-414. PubMed ID: 29788742
[TBL] [Abstract][Full Text] [Related]
11.
Guo H; Zhang B; Nairn AV; Nagy T; Moremen KW; Buckhaults P; Pierce M
J Biol Chem; 2017 Mar; 292(10):4123-4137. PubMed ID: 28096468
[TBL] [Abstract][Full Text] [Related]
12. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N
Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells.
Itkonen HM; Minner S; Guldvik IJ; Sandmann MJ; Tsourlakis MC; Berge V; Svindland A; Schlomm T; Mills IG
Cancer Res; 2013 Aug; 73(16):5277-87. PubMed ID: 23720054
[TBL] [Abstract][Full Text] [Related]
14. Nutrient sensor O-GlcNAc transferase controls cancer lipid metabolism via SREBP-1 regulation.
Sodi VL; Bacigalupa ZA; Ferrer CM; Lee JV; Gocal WA; Mukhopadhyay D; Wellen KE; Ivan M; Reginato MJ
Oncogene; 2018 Feb; 37(7):924-934. PubMed ID: 29059153
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
[TBL] [Abstract][Full Text] [Related]
16. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
Goldberg H; Whiteside C; Fantus IG
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Livin inhibits growth and invasion of gastric cancer cells through blockade of the MAPK pathway in vitro and in vivo.
Ou JM; Ye B; Qiu MK; Dai YX; Dong Q; Shen J; Dong P; Wang XF; Liu YB; Quan ZW; Fei ZW
Int J Oncol; 2014 Jan; 44(1):276-84. PubMed ID: 24220265
[TBL] [Abstract][Full Text] [Related]
18. o-GlcNAc transferase is activated by CaMKIV-dependent phosphorylation under potassium chloride-induced depolarization in NG-108-15 cells.
Song M; Kim HS; Park JM; Kim SH; Kim IH; Ryu SH; Suh PG
Cell Signal; 2008 Jan; 20(1):94-104. PubMed ID: 18029144
[TBL] [Abstract][Full Text] [Related]
19. High OGT activity is essential for MYC-driven proliferation of prostate cancer cells.
Itkonen HM; Urbanucci A; Martin SE; Khan A; Mathelier A; Thiede B; Walker S; Mills IG
Theranostics; 2019; 9(8):2183-2197. PubMed ID: 31149037
[TBL] [Abstract][Full Text] [Related]
20.
Sekine H; Okazaki K; Kato K; Alam MM; Shima H; Katsuoka F; Tsujita T; Suzuki N; Kobayashi A; Igarashi K; Yamamoto M; Motohashi H
Mol Cell Biol; 2018 Sep; 38(17):. PubMed ID: 29941490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
